RegionAl: an Optimized Regional Classifier to Predict Mortality in

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

Pulmonary Function Testing
Sandra G. Adams, MD, MS Pulmonary Diseases / Critical Care Medicine University of Texas Health Science Center at San Antonio South Texas Veterans Healthcare.
Academy Board Prep PCCM
Chronic Obstructive Pulmonary Disease Research Opportunity Chronic Obstructive Pulmonary Disease (COPD) Dr Ian Williams Greater Metro South Brisbane Medicare.
QUANTITATIVE RISK STRATIFICATION IN MARKOV CHAINS WITH QUASI-STATIONARY DISTRIBUTIONS David C Chan, MD, MSc 1 ; Philip K Pollett, PhD 2 ; Milton C Weinstein,
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Decreasing Hospital LOS for Bronchiolitis Sandweiss DR, Mundorff MB, Hill T, et al.
Clinical application 1.Dx exercise intolerance 1.1  VO 2 max   VO 2 AT 1.2 RER >1.2 (HRmax is not achieved) 1.3  breathing reserve < 20% (N=20-40%)
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
Practice Support Program in COPD: South Okanagan Project COPD CARE Algorithm South Okanagan, Interior Health Patricia Rattee RRT, CRE Shannon Walker MD,
23 augusti 2015Veronica Vicente1 Track 8: Clinical Geriatrics Randomized Controlled Trial of a Prehospital Decision System by Emergency Medical Services.
Darren A. DeWalt, MD, MPH Division of General Internal Medicine Maihan B. Vu, Dr.PH, MPH Center for Health Promotion and Disease Prevention University.
Interpretation Normal Spirometry Obstructive pattern Restrictive pattern Mixed pattern Small airway obstruction Non-specific ventilatory pattern Probably.
Surveillance for Asthma: Measuring a Moving Target David M. Mannino Air Pollution and Respiratory Health Branch Centers for Disease Control and Prevention.
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group,
Security and Privacy Practices for Electronic Health Records Joseph W. Hales, PhD, FACMI Intermountain Healthcare Salt Lake City, UT.
Lung Function Tests Normal and abnormal Prof. J. Hanacek, MD, PhD.
Normal and abnormal Prof. J. Hanacek, MD, PhD
Acknowledgements Contact Information Anthony Wong, MTech 1, Senthil K. Nachimuthu, MD 1, Peter J. Haug, MD 1,2 Patterns and Rules  Vital signs medoids.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Focus Area 24 Respiratory Diseases Progress Review June 29, 2004.
An Approach For Spirometry and DLCO Interpretation
Easter 2007 in London. Defining better measures of emergency readmission Eren Demir, Thierry Chaussalet, Haifeng Xie
A-1 Introduction Pravastatin-Aspirin 7asdf Fred T. Fiedorek, M.D. Vice President, Clinical Design & Evaluation, Metabolics Pharmaceutical Research Institute.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
● The results of this study suggest that using the prognostic test to guide ACT decisions in NSCLC is cost-effective compared to a SoC approach according.
1. Identify patients in our practice with a diagnosis of asthma or presumed asthma who have not had formal pulmonary function testing or in house spirometry.
Wales Primary Care COPD Audit
HelpDesk Answers Evaluating the Evidence (Strength of Recommendations)
Amber E. Barnato, MD, MPH, MS, Elan D. Cohen, MS, Keili A
Critically Appraising a Medical Journal Article
Stephen Joseph Galli, MD  Journal of Allergy and Clinical Immunology 
PFT of the Day!.
Trends in Use of Pulmonary Rehabilitation Among Older Adults with Chronic Obstructive Pulmonary Disease Anita C. Mercado, Shawn P. Nishi, Wei Zhang, Yong-Fang.
L. V. Luna Diaz1,2, I. Iupe2, B. Zavala2, K. Balestrini1, A. M
Rajat Kalra, MBChB1, Pankaj Arora, MD, FAHA2, Charity Morgan, PhD3,
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology PET Measurements of Myocardial Blood flow Post Myocardial.
Obesity and pulmonary function testing
GARD/NCD Action Plan & 2011 UN Summit on NCDs
Kyrgyz State Medical Academy
Conformation Window Size Joint Sensitivity Analysis
Medication Use Pattern Mining for Childhood Pneumonia Using Six Year Inpatient Electronic Medical Records in a Shanghai Hospital, China Chunlei Tang, PhD1,2,3,
The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD
Asthma Phenotypes Defined From Parameters Obtained During Recovery From a Hospital-Treated Exacerbation  Rihuang Qiu, MD, Jiaxing Xie, MD, PhD, Kian Fan.
David B. Price, MBBChir, MA, FRCGP, Barbara P
2Loma Linda University Medical Center, Loma Linda, CA
Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G
Grampian COPD MCN Delivering Spirometry in a Community Pharmacy setting, a rural solution? Small I (1,2), Clelland J (1,2), Robertson W (1), Freeman D.
Clustering Similar Clinical Documents in Electronic Health Records
قسمت دوم مربوط به فایل Pulmonary Function Test قسمت دوم مربوط به فایل.
A Clinical Study of COPD Severity Assessment by Primary Care Physicians and Their Patients Compared with Spirometry  Douglas W. Mapel, MD, MPH, Anand.
Clinical application Dx exercise intolerance 1.1  VO2max   VO2 AT
Interpretation Normal Spirometry Obstructive pattern
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Amber E. Barnato, MD, MPH, MS, Elan D. Cohen, MS, Keili A
Risk Stratification and Interventional Cardiology: Robert L
The Impact of EuroSCORE II Risk Factors on Prediction of Long-Term Mortality  Fabio Barili, MD, PhD, Davide Pacini, MD, Mariangela D’Ovidio, MS, Nicholas.
Scalable and accurate deep learning with electronic health
Volume 154, Issue 6, Pages (December 2018)
Abandoning FEV1/FVC <0.70 to Detect Airway Obstruction
Improving the Use of Medications to Treat Complex Health Problems in Resource-Poor Settings: Community-Based Examples from Haiti and Peru Jennifer Furin,
Images in Emergency Medicine
Patient engagement with digital therapeutic leads to reduction of A1C and costs in T2DM patients: Cost savings are correlated to both A1C drops as well.
COPD Chronic Obstructive Lung Disease
Consultant Clinical Biochemist
A Data Reconstruction Algorithm for Temporal Clinical Expressions Zhikun Zhang, BS1,2, Chunlei Tang, PhD3,4,5, Meihan Wan, BS1,2, Joseph M. Plasek, PhD3,
Acute and Chronic Seizures in Patients Older Than 60 Years
COPD Chronic Obstructive Lung Disease
Registered Nurse’s Use of HIT, 2006: Findings from a National Survey
Haokai Sheng, Yun Xiong, David W. Bates, Li Zhou
Presentation transcript:

RegionAl: an Optimized Regional Classifier to Predict Mortality in Chronic Obstructive Pulmonary (COPD)Disease Patients Haohan Zhang, Chunlei Tang, PhD, Joseph M. Plasek, Yun Xiong, PhD, Jing Ma, MD, PhD, Li Zhou, MD, PhD, David W. Bates, MD Importance Results Materials and Methods Discussion and Conclusion Studies have shown that there exists a mismatch between patients’ wishes and actual care at the end of life. In United States, up to 60% of deaths happen in an acute care hospital, with patients receiving aggressive care in their final days due to physicians’ tendency to over-estimate prognoses or their ability to treat the patients. Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality in America; affecting an estimated 14.7 million adult Americans diagnosed annually with COPD. Observing similar COPD conditions within a particular COPD stage is very important due to COPD’s slow progression. Materials: We extracted a cohort containing 15,500 COPD patients who had received care at Partners Healthcare network and died between 2011 and 2017 from Partners research patient data registry. Methods: We propose an algorithm called Region Atlas (RegionAl), which is an optimized variant of our previously-developed regional classifier based on a spiral timeline. We focus on two aspects of optimization. Designing an automatic procedure to identify representative sentences by extracting the initial sentences containing a fixed minimum of 30 percent of words that map to a specific topic identified by Latent Dirichlet Allocation. Using a tolerance range to achieve window (i.e., time interval) enlargement. Tolerance range is defined as the distance of observing similar COPD conditions between the upper and lower specification limit. Given a fixed disjoint n-day window as interval, the tolerance range is This method is an improvement upon our previously developed regional classifier. Tang C, Zhang H, et al. Developing a Regional Classifier to Track Patient Needs in Medical Literature Using Spiral Timelines on a Geographical Map. Proceedings of the IEEE BIBM 2017; 864-869. RegionAl is able to 1) efficiently give a probability of death for the individual patient by comparing a particular clinical document with the atlas under the permissible tolerance range; and 2) to visualize COPD conditions. The experimental results demonstrate that RegionAl produces interpretable, accurate, and reliable results in estimating COPD mortality. The atlas could also address a proxy problem – to predict the probability of death for a given patient within a permissible tolerance range, and to help make recommendations for palliative care referral. Future work will evaluate our algorithm using diverse data sets with different mortality rates and from different data resources. Spiral Atlas Results Author Affiliations Shanghai Key Laboratory of Data Science, Fudan University, Shanghai, CHN; Division of General Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Clinical and Quality Analysis, Partners HealthCare System, Boston, MA, USA; Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, UT, USA; Department of Population Medicine, Harvard Medical School, Boston, MA, USA. Figure 1. A spiral atlas with representative sentences Sentence Representations These data demonstrate a very severe (FEV1 <35% of predicted) obstructive ventilatory deficit. These data suggest a severe (FVC between 35 and 49% of predicted) restrictive ventilatory deficit. Nonspecific T wave abnormality now evident in Inferior leads. LDA results FVC normal reduced FEV1 data predicted FEV1/FVC bronchodilator severe deficit restrictive suggest TLC abnormality spirometry moderate change diffusion range interpretation flow obstructive critical evident demonstrate wave 180 to 270 days before death 90 to 180 days before death …… 270 to 360 days before death 0 to 90 days before death 630 to 720 days before death 1 360 to 450 days before death 450 to 540 days before death 540 to 630 days before death 0 to 65 days before death (b) time intervals changed by the tolerance range c) pulmonary notes within 0 to 65 days before death. (a) a 90-day spiral atlas

RegionAl: an Optimized Regional Classifier to Predict Mortality in Chronic Obstructive Pulmonary (COPD)Disease Patients Haohan Zhang, Chunlei Tang, PhD, Joseph M. Plasek, Yun Xiong, PhD, Jing Ma, MD, PhD, Li Zhou, MD, PhD, David W. Bates, MD Importance Results Materials and Methods Discussion and Conclusion Studies have shown that there exists a mismatch between patients’ wishes and actual care at the end of life. In United States, up to 60% of deaths happen in an acute care hospital, with patients receiving aggressive care in their final days due to physicians’ tendency to over-estimate prognoses or their ability to treat the patients. Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality in America; affecting an estimated 14.7 million adult Americans diagnosed annually with COPD. Observing similar COPD conditions within a particular COPD stage is very important due to COPD’s slow progression. Materials: We extracted a cohort containing 15,500 COPD patients who had received care at Partners Healthcare network and died between 2011 and 2017 from Partners research patient data registry. Methods: We propose an algorithm called Region Atlas (RegionAl), which is an optimized variant of our previously-developed regional classifier based on a spiral timeline. We focus on two aspects of optimization. Designing an automatic procedure to identify representative sentences by extracting the initial sentences containing a fixed minimum of 30 percent of words that map to a specific topic identified by Latent Dirichlet Allocation. Using a tolerance range to achieve window (i.e., time interval) enlargement. Tolerance range is defined as the distance of observing similar COPD conditions between the upper and lower specification limit. Given a fixed disjoint n-day window as interval, the tolerance range is This method is an improvement upon our previously developed regional classifier. Tang C, Zhang H, et al. Developing a Regional Classifier to Track Patient Needs in Medical Literature Using Spiral Timelines on a Geographical Map. Proceedings of the IEEE BIBM 2017; 864-869. RegionAl is able to 1) efficiently give a probability of death for the individual patient by comparing a particular clinical document with the atlas under the permissible tolerance range; and 2) to visualize COPD conditions. The experimental results demonstrate that RegionAl produces interpretable, accurate, and reliable results in estimating COPD mortality. The atlas could also address a proxy problem – to predict the probability of death for a given patient within a permissible tolerance range, and to help make recommendations for palliative care referral. Future work will evaluate our algorithm using diverse data sets with different mortality rates and from different data resources. Spiral Atlas Results Author Affiliations Shanghai Key Laboratory of Data Science, Fudan University, Shanghai, CHN; Division of General Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Clinical and Quality Analysis, Partners HealthCare System, Boston, MA, USA; Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, UT, USA; Department of Population Medicine, Harvard Medical School, Boston, MA, USA. Figure 1. A spiral atlas with representative sentences Sentence Representations These data demonstrate a very severe (FEV1 <35% of predicted) obstructive ventilatory deficit. These data suggest a severe (FVC between 35 and 49% of predicted) restrictive ventilatory deficit. Nonspecific T wave abnormality now evident in Inferior leads. LDA results FVC normal reduced FEV1 data predicted FEV1/FVC bronchodilator severe deficit restrictive suggest TLC abnormality spirometry moderate change diffusion range interpretation flow obstructive critical evident demonstrate wave 180 to 270 days before death 90 to 180 days before death …… 270 to 360 days before death 0 to 90 days before death 630 to 720 days before death 2 360 to 450 days before death 450 to 540 days before death 540 to 630 days before death 0 to 65 days before death (b) time intervals changed by the tolerance range c) pulmonary notes within 0 to 65 days before death. (a) a 90-day spiral atlas